Obesity and obstructive sleep apnea - Clinical significance of weight loss

Sleep Medicine Reviews

Volumn 17, Issue 5, 2013, Pages 321-329

  Tuomilehto, Henri ^a   Seppä, Juha ^b   Uusitupa, Matti ^b,c  

^a Oivauni Sleep Clinic   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Bariatric surgery; Diet; Lifestyle intervention; Metabolic syndrome; Obstructive sleep apnea; Physical activity; Treatment; Weight loss

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BARIATRIC SURGERY; BLOOD PRESSURE; BODY MASS; GLUCOSE TOLERANCE; HEALTH CARE COST; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; RESPIRATORY FUNCTION; REVIEW; SLEEP DISORDERED BREATHING; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIET; LIFESTYLE INTERVENTION; METABOLIC SYNDROME; OBSTRUCTIVE SLEEP APNEA; PHYSICAL ACTIVITY; TREATMENT; WEIGHT LOSS;

HUMANS; OBESITY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 84881262831     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2012.08.002     Document Type: Review

References (91)

1. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. JAm Coll Cardiol 2009, 53:1925-1932.
2. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., et al. General and abdominal adiposity and risk of death in Europe. NEngl J Med 2008, 359:2105-2120.
3. Wolk R., Shamsuzzaman A.S., Somers V. Obesity, sleep apnea, and hypertension. Hypertension 2003, 42:1067-1074.
4. Young T., Skatrud J., Peppard P.E. Risk factors for obstructive sleep apnea in adults. JAMA 2004, 291:2013-2016.
5. Young T., Peppard P., Shahrad T. Excess weight and sleep-disordered breathing. JAppl Physiol 2005, 99:1592-1599.
6. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. NEngl J Med 2000, 342:1378-1384.
7. Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., Wilding J.P. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004, 25:735-741.
8. Hiestand D.M., Britz P., Goldman M., Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population. Result from the National Sleep Foundation Sleep in America 2005 Poll. Chest 2006, 130:780-786.
9. Partinen M., Guilleminault C. Daytime sleepiness and cardiovascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990, 97:27-32.
10. Tuomilehto H., Peltonen M., Partinen M., Seppä J., Saaristo Timo, Korpi-Hyövälti Eeva, et al. Sleep-disordered breathing is related to an increased risk for type 2 diabetes in middle-aged men, but not in women - the FIN D2D-survey. Diabetes Obes Metab 2008, 10:468-475.
11. Finn L., Young T.B., Palta M., Frybeck D.G. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998, 21:701-706.
12. Punjabi N.M., Caffo B.S., Goodwin J.L., Gottlieb D.J., Newman A.B., O'Connor G.T., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6:e1000132.
13. Kajaste S., Telakivi T., Mustajoki P., Pihl S., Partinen M. Effects of cognitive-behavioural weight loss programme on overweight obstructive sleep apnoea. Sleep Res 1994, 3:245-249.
14. Kansanen M., Vanninen E., Tuunainen A., Pesonen P., Tuononen V., Hartikainen J., et al. The effects of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998, 4:377-385.
15. Smith P., Gold A., Meyers D., Haponik E., Bleecker E. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985, 103:850-855.
16. Suratt P.M., McTier R.F., Findley L.J., Pohl S.L., Wilhoit S.C. Effect of very-low-calorie diets with weight loss on obstructive sleep apnea. Am J Clin Nutr 1992, 56:182S-184S.
17. Kajaste S., Brander P.E., Telakivi T., Partinen M., Mustajoki P. Acognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004, 5:125-131.
18. Dixon J.B., Schachter L.M., O'Brien P.E. Polysomnography before and after weight loss in obese patients with severe sleep apnoea. Int J Obes 2005, 29:1048-1054.
19. Lettieri C.J., Eliasson A.H., Greenburg D.L. Persistence of obstructive sleep apnea after surgical weight loss. JClin Sleep Med 2008, 4:333-338.
20. Veasey S.C., Guilleminault C., Strohl K.P., Sanders M.H., Ballard R.D., Magalang U.J. Medical therapy for obstructive sleep apnoea: a review by medical therapy for obstructive sleep apnea task force of the standards of practice committee of the American Academy of Sleep Medicine. Sleep 2006, 29:1036-1044.
21. Tuomilehto H., Seppä J., Partinen M., Peltonen M., Gylling H., Tuomilehto J., et al. Lifestyle intervention with weight reduction-first line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med 2009, 179:320-327.
22. Foster G.D., Borradaile K.E., Sanders M.H., Millman R., Zammit G., Newman A.B., et al. Arandomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med 2009, 169:1619-1626.
23. Johansson K., Neovius M., Lagerros Y.T., Harlid R., Rössner S., Granath F., et al. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. BMJ 2009, 339:b4609. 10.1136/bmj.b4609.
24. Johansson K., Hemmingsson E., Harlid R., Trolle Lagerros Y., Granath F., Rössner S., et al. Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. BMJ 2011 Jun 1, 342:d3017. 10.1136/bmj.d3017.
25. Tuomilehto H., Gylling H., Peltonen M., Martikainen T., Sahlman J., Kokkarinen J., et al. Sustained improvement in mild obstructive sleep apnea by diet and physical activity based lifestyle intervention- post-interventional follow-up. Am J Clin Nutr 2010, 92:688-692.
26. World Health Organization. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/.
27. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307:491-497.
28. Peltonen M., Harald K., Männistö S., Saarikoski L., Peltomäki P., Lund L., et al. The National FINRISK 2007 study 2008, B34. Publications of the National Public Health Institute. http://www.ktl.fi/portal/2920.
29. Finkelstein E.A., Brown D.S., Wrage L.A., Allaire B.T., Hoerger T.J. Individual and aggregate years-of-life-lost associated with overweight and obesity. Obesity 2010, 18:333-339.
30. Withrow D., Alter D.A. The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2010, 12:131-141.
31. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165:1217-1239.
32. Ronald J., Delaive K., Roos L., Manfreda J.H., Kryger M.H. Obstructive sleep apnea patients use more health resources ten years prior to diagnosis. Sleep Res Online 1998, 1:71-74.
33. Pillar G., Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg?. Diabetes Care 2008, 31:303-309.
34. Patil S.P., Schneider H., Schwartz A.R., Smith P.L. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 2007, 132:325-337.
35. American Academy of Sleep Medicine Task Force Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999, 22:667-689.
36. Schwartz A.R., Patil S.P., Squier S., Schneider H., Kirkness J.P., Smith P.L. Obesity and upper airway control during sleep. JAppl Physiol 2010, 108:430-435.
37. Bonsignore M.R., McNicholas W.T., Montserrat J.M., Eckel J. Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J 2012, 39:746-767.
38. Horner R., Mohiaddin R., Lowell D., Shea S.A., Burman E.D., Longmore D.B., et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989, 2:613-622.
39. Schwartz A.R., Gold A.R., Schubert N., Stryzak A., Wise A.R., Permutt S., et al. Effect of weight loss on upper airway collapsibility on obstructive sleep apnea. Am Rev Respir Dis 1991, 144:494-498.
40. Strobel R.J., Rosen R.C. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep 1996, 19:104-115.
41. Hlavac M.C., Catcheside P.G., McDonald R., Eckert D.J., Windler S., McEvoy R.D. Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep. Sleep 2006, 29:624-631.
42. Peppard P.E., Ward N.R., Morrell M.J. The impact of obesity on oxygen desaturation during sleep-disordered breathing. Am J Respir Crit Care Med 2009, 180:788-793.
43. Spiegel K., Tasali E., Penev P., Van Cauter E. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
44. Stenlöf K., Grunstein R., Hedner J., Sjöström L. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 1996, 271:E1036-E1043.
45. Newman A.B., Foster G., Givelber R., Nieto F.J., Redline S., Young T. Progression and regression of sleep-disorders breathing with changes in weight. Arch Intern Med 2005, 165:2408-2413.
46. Uusitupa M., Tuomilehto J., Puska P. Are we really active in the prevention of obesity and type 2 diabetes at the community level?. Nutr Metab Cardiovasc Dis 2011, 21:380-389.
47. Phillips C.L., Yee B.J., Trenell M.I., Magnussen J.S., Wang D., Banerjee D., et al. Changes in regional adiposity and cardio-metabolic function following a weight loss program with sibutramine in obese men with obstructive sleep apnea. JClin Sleep Med 2009, 5:416-421.
48. Yee B.J., Phillips C.L., Banerjee D., Caterson I., Hedner J.A., Grunstein R.R. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. Int J Obes 2007, 31:161-168.
49. Barvaux V.A., Aubert G., Rodenstein D.O. Weight loss as a treatment for obstructive sleep apnoea. Sleep Med Rev 2000, 4:435-452.
50. Knowler W.C., Fowler S.E., Hamman R.F., Christophi C.A., Hoffman H.J., Brenneman A.T., et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686.
51. Lindström J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemiö K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673-1679.
52. Saaristo T., Moilanen L., Korpi-Hyövälti E., Vanhala M., Saltevo J., Niskanen L., et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish national diabetes prevention program (FIN-D2D). Diabetes Care 2010, 33:2146-2151.
53. Berger G., Berger R., Oksenberg A. Progression of snoring and obstructive sleep apnoea: the role of increasing weight and time. Eur Respir J 2009, 33:338-345.
54. Peppard P.E., Young T. Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep 2004, 27:480-484.
55. Laaksonen D.E., Lindström J., Tuomilehto J., Uusitupa M., Finnish Diabetes Prevention Study Group Increased physical activity is a cornerstone in the prevention of type 2 diabetes in high-risk individuals. Diabetologia 2007, 50:2607-2608.
56. Li R., Zhang P., Barker L.E., Chowdhury F.M., Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2010, 33:1872-1894.
57. North American Association for the Study of Obesity and the National Heart, Lung, and Blood Institute The practical guide: identification, evaluation, and treatment of overweight and obesity in adults 2000, National Institutes of Health, Bethesda, Md, NIH pubLication 00-4084.
58. Buchwald H., Oien D.M. Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009, 19:1605-1611.
59. Population, overweight and obesity prevalence. Europe in figures: Eurostat Yearbook 2006-07 2007, Office for Official Publications of the European Communities, Luxembourg.
60. NIH Conference Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med 1991, 115:956-961.
61. Greenburg D.L., Lettieri C.J., Eliasson A.H. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 2009, 122:535-542.
62. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
63. Lankford D.A., Proctor C.D., Richard R. Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss. Obes Surg 2005, 15:336-341.
64. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 Oct 20, 120(16):1640-1645.
65. Nock N.L., Li L., Larkin E.K., Patel S.R., Redline S. Empirical evidence for "syndrome Z": a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures. Sleep 2009, 32:615-622.
66. Tasali E., Mokhlesi B., Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008, 133:496-506.
67. Lévy P., Bonsignore M.R., Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009, 34:243-260.
68. Huffman D.M., Barzilai N. Role of visceral adipose tissue in aging. Biochem Biophys Acta 2009, 1790:1117-1123.
69. Després J.P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
70. McArdle N., Hillman D., Beilin L., Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007, 175:190-195.
71. Shamsuzzaman A.S., Gersh B.J., Somers V.K. Obstructive sleep apnea. Implications for cardiac and vascular disease. JAMA 2003, 290:1906-1913.
72. Ryan S., Taylor C.T., McNicholas W.T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?. Thorax 2009, 64:631-636.
73. Sahlman J., Peltonen M., Miettinen K., Punnonen K., Peuhkurinen K., Vanninen E., et al. Activation of inflammatory cytokine system in mild obstructive sleep apnoea. JSleep Res 2010, 19:341-348.
74. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G.N. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
75. Sahlman J., Pukkila M., Seppa J., Tuomilehto H. Evolution of mild obstructive sleep apnea after different treatments. Laryngoscope 2007, 117:1107-1111.
76. Young T., Finn L., Peppard P.E., Szklo-Coxe M., Austin D., Nieto F.J., et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31:1071-1078.
77. Marshall N.S., Wong K.K., Liu P.Y., Cullen S.R., Knuiman M.W., Grunstein R.R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008, 31:1079-1085.
78. Sahlman J, Seppä J, Herder C, Peltonen M, Peuhkurinen K, Gylling H, etal. Effect of weight loss on inflammation in patients with mild obstructive sleep apnea. Nutr Metab Cardiovasc Dis. 2010 Dec 28. [Epub ahead of print].
79. Barnes M., Goldsworthy U.R., Cary B.A., Hill C.J. Adiet and exercise program to improve clinical outcomes in patients with obstructive sleep apnea-a feasibility study. JClin Sleep Med 2009, 5:409-415.
80. Noseda A., Kempenaers C., Kerkhofs M., Houben J.J., Linkowski P. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Potential for weaning from continuous positive airway pressure. Chest 1996, 109:138-143.
81. Sugerman H.J., Fairman R.P., Sood R.K., Engle K., Wolfe L., Kellum J.M. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992, 55:597S-601S.
82. Charuzi I., Lavie P., Peiser J., Peled R. Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. Am J Clin Nutr 1992, 55:594S-596S.
83. Peiser J., Lavie P., Ovnat A., Charuzi I. Sleep apnea syndrome in the morbidly obese as an indication for weight reduction surgery. Ann Surg 1984, 199:112-115.
84. Harman E.M., Wynne J.W., Block A.J. The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest 1982, 82:291-294.
85. Ilanne-Parikka P., Eriksson J.G., Lindström J., Peltonen M., Aunola S., Hämäläinen H., et al. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 2008, 31:805-807.
86. Bo S., Ciccone G., Baldi C., Benini L., Dusio F., Forastiere G., et al. Effectiveness of a lifestyle intervention on metabolic syndrome. A randomized controlled trial. JGen Intern Med 2007, 22:1695-1703.
87. Wing R.R., for Look AHEAD Research Group Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010, 170:1566-1575.
88. Foster G.D., Wyatt H.R., Hill J.O., Makris A.P., Rosenbaum D.L., Brill C., et al. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 2010, 153:147-157.
89. Goodpaster B.H., Delany J.P., Otto A.D., Kuller L., Vockley J., South-Paul J.E., et al. Effects of diet and physical activity interventions on weight loss and metabolic risk factors in severely obese adults: a randomized trial. JAMA 2010, 304:1795-1802.
90. Burke V., Beilin L.J., Cutt H.E., Mansour J., Wilson A., Mori T.A. Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. JHypertens 2005, 23:1241-1249.
91. Kastarinen M.J., Puska P.M., Korhonen M.H., Mustonen J.N., Salomaa V.V., Sundvall J.E., et al. Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomized controlled trial of lifestyle intervention against hypertension in Eastern Finland. JHypertens 2002, 20:2505-2512.